The stable isotope-based dynamic metabolic profile of butyrate-induced HT29 cell differentiation

被引:69
作者
Boren, J
Lee, WNP
Bassilian, S
Centelles, JJ
Lim, S
Ahmed, S
Boros, LG
Cascante, M
机构
[1] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Parc Cient Barcelona,Ctr Rec Quim Teor, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain
[2] Univ Calif Los Angeles, Sch Med, Harbor UCLA Res & Educ Inst, Torrance, CA 90502 USA
关键词
D O I
10.1074/jbc.M302932200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stable isotope-based dynamic metabolic profiling is applied in this paper to elucidate the mechanism by which butyrate induces cell differentiation in HT29 cells. We utilized butyrate-sensitive ( HT29) cells incubated with [1,2-C-13(2)] glucose or [1,2-C-13(2)] butyrate as single tracers to observe the changes in metabolic fluxes in these cells. In HT29 cells, increasing concentrations of butyrate inhibited glucose uptake, glucose oxidation, and nucleic acid ribose synthesis in a dose-dependent fashion. Glucose carbon utilization for de novo fatty acid synthesis and tricarboxylic acid cycle flux was replaced by butyrate. We also demonstrated that these changes are not present in butyrate-resistant pancreatic adenocarcinoma MIA cells. The results suggest that the mechanism by which colon carcinoma cells acquire a differentiated phenotype is through a replacement of glucose for butyrate as the main carbon source for macromolecule biosynthesis and energy production. This provides a better understanding of cell differentiation through metabolic adaptive changes in response to butyrate in HT29 cells, demonstrating that variations in metabolic pathway substrate flow are powerful regulators of tumor cell proliferation and differentiation.
引用
收藏
页码:28395 / 28402
页数:8
相关论文
共 23 条
  • [1] Butyrate and glucose metabolism by colonocytes in experimental colitis in mice
    Ahmad, MS
    Krishnan, S
    Ramakrishna, BS
    Mathan, M
    Pulimood, AB
    Murthy, SN
    [J]. GUT, 2000, 46 (04) : 493 - 499
  • [2] AUGERON C, 1984, CANCER RES, V44, P3961
  • [3] BERGMEYER HV, 1974, METHOD ENZYMAT AN, P860
  • [4] Metabolic control analysis in drug discovery and disease
    Cascante, M
    Boros, LG
    Comin-Anduix, B
    de Atauri, P
    Centelles, JJ
    Lee, PWN
    [J]. NATURE BIOTECHNOLOGY, 2002, 20 (03) : 243 - 249
  • [5] Oncogenic alterations of metabolism
    Dang, CV
    Semenza, GL
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (02) : 68 - 72
  • [6] Genes modulated by histone acetylation as new effecters of butyrate activity
    Della Ragione, F
    Criniti, V
    Della Pietra, V
    Borriello, A
    Oliva, A
    Indaco, S
    Yamamoto, T
    Zappia, V
    [J]. FEBS LETTERS, 2001, 499 (03): : 199 - 204
  • [7] Alterations of MAPK activities associated with intestinal cell differentiation
    Ding, QM
    Wang, QD
    Evers, BM
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 284 (02) : 282 - 288
  • [8] Short chain fatty acids differentially modulate cellular phenotype and c-myc protein levels in primary human nonmalignant and malignant colonocytes
    Emenaker, NJ
    Basson, MD
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2001, 46 (01) : 96 - 105
  • [9] Transcriptional response of a human colon adenocarcinoma cell line to sodium butyrate
    Iacomino, G
    Tecce, MF
    Grimaldi, C
    Tosto, M
    Russo, GL
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 285 (05) : 1280 - 1289
  • [10] Feasibility of analysing [C-13]urea breath tests for Helicobacter pylori by gas chromatography-mass spectrometry in the selected ion monitoring mode
    Kasho, VN
    Cheng, S
    Jensen, DM
    Ajie, H
    Lee, WNP
    Faller, LD
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (06) : 985 - 995